Good Clinical Practice (GCP)
Full course · Clinical Research Foundations
Free Lesson Preview
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeAlready enrolled? Sign in
Why clinical trials are regulated, who the major regulatory authorities are, and how national laws work together with international guidelines to protect research participants and ensure data integrity.
What you will learn5 objectives
By the end of this lesson, you will be able to:
Clinical trials involve something extraordinary: administering experimental treatments to human beings before we know whether those treatments are safe or effective. Healthy volunteers receive compounds that have never before entered a human body. Patients with serious illnesses accept experimental therapies hoping they will help, knowing they might not. This inherent uncertainty creates ethical obligations that cannot be left to individual judgment alone.
Regulation exists because the history of medical research includes failures of ethics and quality that harmed real people. The thalidomide disaster of the 1950s and 1960s left thousands of children with birth defects because a drug was marketed without adequate testing. The Tuskegee syphilis study deceived participants for decades. Industrial accidents and contaminated products have killed people who trusted that medicines were safe.
These failures taught us that good intentions are not enough. Individual investigators, however ethical, can make mistakes in judgment. Companies, however responsible, face pressures that might compromise safety. Participants, however well-informed, cannot evaluate technical evidence themselves. Regulation provides the independent oversight that protects everyone involved.
Progress saves itself — finish reading and this lesson completes
